Creation and implementation of SAMPRO™: A school-based asthma management program - 03/09/16
, Sujani Kakumanu, MD d, Kathleen Shanovich, PNP g, Nicholas Antos, MD b, Michelle M. Cloutier, MD c, Donna Mazyck, MS, RN e, Wanda Phipatanakul, MD, MS f, Shirley Schantz, EdD, ARNP, RN e, Stanley Szefler, MD h, Renee Vandlik, MA i, Paul Williams, MD jAbstract |
Clinicians who care for children with asthma have an obligation to coordinate asthma care with the schools. Aside from routine clinical care of asthmatic children, providers must educate the family and child about the need for an asthma treatment plan in school and support the school nurse meeting the needs of the student requiring school-based asthma care. The following article was developed by multiple stakeholders to address this need. It describes the 4 components of the School-based Asthma Management Program (SAMPRO™). SAMPRO™ details elements necessary for the education of children, families, clinicians, and school-based personnel based on a “circle of support” that would enhance multidirectional communication and promote better care for children with asthma within the school setting.
Le texte complet de cet article est disponible en PDF.Key words : Asthma, school, school nurse, children, asthma action plan, education, environment, triggers
Abbreviations used : AAAAI, AAP, AEP, AMP, EHR, EPA, IAQ, IPM, NASN, SAMPRO™, SBHC
Plan
| Supported by funds provided by the American Academy of Allergy, Asthma & Immunology and the National Association of School Nurses. |
|
| This statement was endorsed by the American Academy of Pediatrics; the American College of Allergy, Asthma & Immunology; the American Thoracic Society; the Allergy & Asthma Network; and the National Association of School Nurses. |
|
| Disclosure of potential conflict of interest: R. F. Lemanske has received travel support from the American Academy of Allergy, Asthma & Immunology (AAAAI); is employed by the University of Wisconsin; has received grants from the National Heart, Lung, and Blood Institute (NHLBI) and Pharmaxis; has received royalties from Elsevier and UpToDate; and has received speaker honoraria from the Kuwait Allergy Society, Lurie Children's Hospital, Boston Children's Hospital, Health Star Communications, LA Children's Hospital, Northwestern University, the Asthma and Allergy Foundation of America–Alaska Chapter, and the Egyptian Allergy Society. S. Kakumano has received royalties from UpToDate. K. Shanovich has received travel support, payment for writing or reviewing the manuscript, and employment from the AAAAI. N. Antos received travel support from the AAAAI School Based Management of Asthma Summit. M. M. Cloutier has received travel support from the AAAAI; has consultant arrangements with ProHealth Physicians; has received grants from the National Institutes of Health, the NHLBI, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; and has received payment for lectures from Nationwide. S. Szefler has consultant arrangements with Roche, AstraZeneca, Aerocrine, Daiichi Sankyo, Boehringer Ingelheim, Genentech, and Novartis and has received grants from GlaxoSmithKline. P. Williams has received travel support from the AAAAI and is employed by Northwest Asthma & Allergy Center. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 138 - N° 3
P. 711-723 - septembre 2016 Retour au numéro
Article précédent
- Roles of Mas-related G protein–coupled receptor X2 on mast cell–mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases
- Hariharan Subramanian, Kshitij Gupta, Hydar Ali
- Clinical trial data access: Opening doors with TrialShare
- Adam L. Asare, Vincent J. Carey, Daniel Rotrosen, Gerald T. Nepom
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?